Pay in 4 interest-free payments of $30.50 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
1007/s12032-013-0546-3
CC(C)C[C@H](NC(=O)C1CSC(=N1)C(N)C(C)CC)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC([O-])=O)NC(=O)[C@@H](CC2=CN=CN2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@@H](CCCN)NC1=O)[C@H](C)CC
Exposure of primary leukemic patient blasts to dBET1 elicits dose-proportionate depletion of BRD4 and induction of apoptosis
Wnt signaling and cancer
2-trifluoroethoxy]pyrimidin-4-yl}phenyl)propanoic acid
m-PEG4-NHS ester 5-Boc 1007/s12032-013-0546-3m PEG4 NHS ester is a PEG based PROTAC linker can be used in the synthesis of PROTACs. Product information CAS Number: 622405 78 1 Molecular Weight: 333. 33 Formula: C14H23NO8 Chemical Name: 2,5 dioxopyrrolidin 1 yl 2,5,8,11 tetraoxatetradecan 14 oate Smiles: COCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O InChiKey: MAYFFZZPEREGBQ UHFFFAOYSA N InChi: InChI=1S C14H23NO8 c1 19 6 7 21 10 11 22 9 8 20 5 4 14(18)23 15 12(16)2 3 13(15)17 h2 11H2,1H3 Technical Data
US$ 116.39
US$ 137.00
US$ 79.95
US$ 79.95